Therefore, our trio whole‐exome analysis robustly indicates that the novel missense variant (c.203 T>G, p.Met68Arg) in SPTLC2 is a causal factor for early‐onset ALS. This evidence concerns the gene SPTLC2 and amyotrophic lateral sclerosis.